208 related articles for article (PubMed ID: 6788849)
1. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells.
Kirch ME; Hammerling U
J Immunol; 1981 Aug; 127(2):805-10. PubMed ID: 6788849
[TBL] [Abstract][Full Text] [Related]
2. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of lymphoid and nonlymphoid tumors with monoclonal anti-Lyt-1 antibodies.
Hollander N
J Immunol; 1984 Nov; 133(5):2801-5. PubMed ID: 6332862
[TBL] [Abstract][Full Text] [Related]
4. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
5. Influence of antibody isotype on passive serotherapy of lymphoma.
Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
[TBL] [Abstract][Full Text] [Related]
6. Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
Badger CC; Krohn KA; Peterson AV; Shulman H; Bernstein ID
Cancer Res; 1985 Apr; 45(4):1536-44. PubMed ID: 3978621
[TBL] [Abstract][Full Text] [Related]
7. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
Sobotková E; Nouza K
Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.
Badger CC; Shulman H; Peterson AV; Bernstein ID
Cancer Res; 1986 Aug; 46(8):4058-63. PubMed ID: 2873885
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to murine cell surface antigens. I. Lyt-1.1.
Hogarth PM; Potter TA; Cornell FN; McLachlan R; McKenzie IF
J Immunol; 1980 Oct; 125(4):1618-24. PubMed ID: 6997382
[TBL] [Abstract][Full Text] [Related]
10. Treatment of murine EL4 leukemia in ascitic form with anti-Thy 1.2 specific immunotoxins.
Marches R; Mota G; Margineanu M; Stavri H; Savi G; Nicolae M; Bancu A; Moraru I
Neoplasma; 1990; 37(5):573-8. PubMed ID: 2234217
[TBL] [Abstract][Full Text] [Related]
11. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
[TBL] [Abstract][Full Text] [Related]
12. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
13. Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.
Badger CC; Bernstein ID
J Exp Med; 1983 Mar; 157(3):828-42. PubMed ID: 6403649
[TBL] [Abstract][Full Text] [Related]
14. The immunotherapeutic effects in tumor-bearing mice of Ly-6 monoclonal antibodies.
Lu L; Palladino MA; DeLeo AB
J Immunol; 1989 Jan; 142(2):719-25. PubMed ID: 2783443
[TBL] [Abstract][Full Text] [Related]
15. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
[TBL] [Abstract][Full Text] [Related]
17. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
[TBL] [Abstract][Full Text] [Related]
18. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
Weiner LM; Holmes M; Adams GP; LaCreta F; Watts P; Garcia de Palazzo I
Cancer Res; 1993 Jan; 53(1):94-100. PubMed ID: 8093231
[TBL] [Abstract][Full Text] [Related]
19. Penetration and binding of antibodies in experimental human solid tumors grown in mice.
Ong GL; Mattes MJ
Cancer Res; 1989 Aug; 49(15):4264-73. PubMed ID: 2743313
[TBL] [Abstract][Full Text] [Related]
20. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
